Company Overview of Targeted Diagnostics & Therapeutics, Inc.
Key Executives for Targeted Diagnostics & Therapeutics, Inc.
|Harry A. Arena||4 Relationships||Chairman of the Board, Chief Executive Officer and President||--|
|David D. Gathman CPA||32 Relationships||Chief Financial Officer and Vice President||69|
|Daniel J. O'Shannessy Ph.D.||No Relationships||Chief Operating Officer||--|
|Alan D. Watson Ph.D., M.B.A||6 Relationships||Chief Business Officer and Executive Vice President||64|
|Arthur V. Boyce Jr.||No Relationships||Vice President of Marketing and Business Development||--|
Targeted Diagnostics & Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Harry A. Arena||4 Relationships||Targeted Diagnostics & Therapeutics, Inc.||--|
|Scott A. Waldman M.D., Ph.D.||4 Relationships||Targeted Diagnostics & Therapeutics, Inc.||--|
|Andre Terzic M.D., Ph.D.||4 Relationships||Mayo Clinic Health System New Prague||--|
|John L. Marshall M.D.||29 Relationships||Caris Life Sciences, Inc.||--|
|Anil K. Rustgi M.D.||52 Relationships||Targeted Diagnostics & Therapeutics, Inc.||--|
Targeted Diagnostics & Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Advisory Board M.D., Ph.D.||Scott A. Waldman||4 Relationships||4 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.